Terms: = Germ cell tumor AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
39 results:
1. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Boateng ST; Roy T; Agbo ME; Mahmud MA; Banang-Mbeumi S; Chamcheu RN; Yadav RK; Bramwell M; Pham LK; Dang DD; Jackson KE; Nagalo BM; Hill RA; Efimova T; Fotie J; Chamcheu JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14418. PubMed ID: 38230791
[TBL] [Abstract] [Full Text] [Related]
2. Galectin-9 promotes natural killer cells activity
Rahmati A; Bigam S; Elahi S
Front Immunol; 2023; 14():1131379. PubMed ID: 37006235
[TBL] [Abstract] [Full Text] [Related]
3. Molecular profiling of core immune-escape genes highlights lck as an immune-related prognostic biomarker in melanoma.
Wang F; Zheng A; Zhang D; Zou T; Xiao M; Chen J; Wen B; Wen Q; Wu X; Li M; Du F; Chen Y; Zhao Y; Shen J; Xiang S; Li J; Deng S; Zhang Z; Yi T; Xiao Z
Front Immunol; 2022; 13():1024931. PubMed ID: 36341345
[TBL] [Abstract] [Full Text] [Related]
4. CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive cell Infiltration as an Inspiring Biomarker of Survivance.
Ma K; Chen S; Chen X; Zhao X; Yang J
J Mol Neurosci; 2022 Oct; 72(10):2106-2124. PubMed ID: 36006582
[TBL] [Abstract] [Full Text] [Related]
5. PPP2R2D Suppresses Effector T cell Exhaustion and Regulatory T cell Expansion and Inhibits tumor Growth in Melanoma.
Pan W; Scherlinger M; Yoshida N; Tsokos MG; Tsokos GC
J Immunol; 2022 Aug; 209(3):621-628. PubMed ID: 35831019
[TBL] [Abstract] [Full Text] [Related]
6. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Ma K; Chen S; Chen X; Yang C; Yang J
World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
[TBL] [Abstract] [Full Text] [Related]
7. CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.
Ma K; Chen X; Liu W; Chen S; Yang C; Yang J
Sci Rep; 2022 Mar; 12(1):4295. PubMed ID: 35277559
[TBL] [Abstract] [Full Text] [Related]
8. Association Between Melanoma Detected During Routine Skin Checks and Mortality.
Watts CG; McLoughlin K; Goumas C; van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE
JAMA Dermatol; 2021 Dec; 157(12):1425-1436. PubMed ID: 34730781
[TBL] [Abstract] [Full Text] [Related]
9. ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.
Ma K; Chen X; Liu W; Yang Y; Chen S; Sun J; Ma C; Wang T; Yang J
Sci Rep; 2021 Oct; 11(1):20839. PubMed ID: 34675316
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract] [Full Text] [Related]
11. Asparagine enhances lck signalling to potentiate CD8
Wu J; Li G; Li L; Li D; Dong Z; Jiang P
Nat Cell Biol; 2021 Jan; 23(1):75-86. PubMed ID: 33420490
[TBL] [Abstract] [Full Text] [Related]
12. CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
Liu F; Huang J; He F; Ma X; Fan F; Meng M; Zhuo Y; Zhang L
Sci Rep; 2020 Jul; 10(1):10768. PubMed ID: 32612110
[TBL] [Abstract] [Full Text] [Related]
13. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
[TBL] [Abstract] [Full Text] [Related]
14. lck expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
Ge L; Xu L; Lu S; Yan H
FEBS Open Bio; 2020 May; 10(5):904-911. PubMed ID: 32237064
[TBL] [Abstract] [Full Text] [Related]
15. Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.
Liu F; Huang J; Xiong Y; Li S; Liu Z
Aging (Albany NY); 2019 Aug; 11(15):5463-5482. PubMed ID: 31377744
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a lck targeted inhibitor.
Zepecki JP; Snyder KM; Moreno MM; Fajardo E; Fiser A; Ness J; Sarkar A; Toms SA; Tapinos N
Oncogene; 2019 Mar; 38(10):1734-1750. PubMed ID: 30353164
[TBL] [Abstract] [Full Text] [Related]
17. Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas.
Wang PF; Cai HQ; Zhang CB; Li YM; Liu X; Wan JH; Jiang T; Li SW; Yan CX
J Neuroinflammation; 2018 May; 15(1):145. PubMed ID: 29764444
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network
Cell; 2015 Jun; 161(7):1681-96. PubMed ID: 26091043
[TBL] [Abstract] [Full Text] [Related]
19. Identification of targets for rational pharmacological therapy in childhood craniopharyngioma.
Gump JM; Donson AM; Birks DK; Amani VM; Rao KK; Griesinger AM; Kleinschmidt-DeMasters BK; Johnston JM; Anderson RC; Rosenfeld A; Handler M; Gore L; Foreman N; Hankinson TC
Acta Neuropathol Commun; 2015 May; 3():30. PubMed ID: 25990246
[TBL] [Abstract] [Full Text] [Related]
20. Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Huang C; Sheng Y; Jia J; Chen L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C114-24. PubMed ID: 25450268
[TBL] [Abstract] [Full Text] [Related]
[Next]
